VeNaV Consulting provides scientific, project management and operational services within Translational Medicine, specializing in DMPK and Chemistry-Biology-Pharmacology interfaces.
Each project is unique. We support with the same enthusiasm a broad spectrum of clients across the globe: Pharma/Biotech, medical devices, in-vitro diagnostics, academic institutions, ONG.
Services offered, among others, are:
▪ DMPK project management: strategy planning, target assessment, hit/lead optimization & characterization, package preparation for entry into clinics, basic PK predictions (IVIVE, DDI, first-in-human dose), due diligence reviews, in/out-licensing activities.
▪ Drug Clinical support: PK oversight, contribution to clinical trial design.
▪ In-house/Outsourcing of DMPK/PD and Toxicology studies: design/evaluation/troubleshooting of in-vitro ADME studies, animal PK/Toxicokinetic/Pharmacodynamic, Pharmacology/Biocompatibility assessments, other Bioanalytical activities. Full outsourcing workflow to CROs following current GxP rules and guidelines (ICH, FDA, EMA).
▪ Scientific Writing: Filing of regulatory packages for drugs (IB/IND/IMPD) and Medical Devices (MDR), scientific publications, reports.
This is not a limited list, please contact us to get tailored support to your idea
consulting@venav.org
Company Details
- Founded
- -
- Address
- Altdorf Ur, Uri 6460, Ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- within Translational Medicine.
- HQ
- Altdorf UR, Uri
Venav Consulting Questions
Venav Consulting's LinkedIn profile is https://ch.linkedin.com/company/venav-consulting
Venav Consulting's industry is
Biotechnology Research
Venav Consulting's top competitors are
Clinsol Gmbh & Co. Kg,
Rejuveron Vascular Therapeutics Ag,
Parexel International (Ch) Ag,
Clinassess,
Galser Sa,
Cebis,
Cross Alliance®,
Palleos,
Rodanotech,
Cebis International.
Venav Consulting's categories are Biotechnology Research
Venav Consulting's founding year is 2021
